Project Details
Description
A Phase 2, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Efficacy of SPR001 in Adults with Classic Congenital Adrenal Hyperplasia (CAH) - SPR001-201
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/17 → 5/30/22 |
Funding
- SPRUCE BIOSCIENCES, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.